Eklund, C M <br/><br/>
C-reactive protein haplotype is associated with high PSA as a marker of metastatic prostate cancer but not with overall cancer risk.  [electronic resource] 

 -  British journal of cancer  Jun 2009 
 - 1846-51 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1532-1827 
<br/><br/><label>Standard No.: </label>10.1038/sj.bjc.6605081  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Aged<br/>Biomarkers, Tumor--blood<br/>Bone Neoplasms--blood<br/>C-Reactive Protein--genetics<br/>Case-Control Studies<br/>Genome-Wide Association Study<br/>Genotype<br/>Haplotypes--genetics<br/>Humans<br/>Male<br/>Middle Aged<br/>Neoplasm Staging<br/>Polymorphism, Single Nucleotide--genetics<br/>Prognosis<br/>Prostate-Specific Antigen--blood<br/>Prostatic Neoplasms--blood<br/>Risk Factors<br/>Survival Rate<br/>Treatment Outcome<br/>Young Adult